XML 22 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
6 Months Ended
Sep. 30, 2017
Financial Instruments [Abstract]  
Financial Instruments
(3) FINANCIAL INSTRUMENTS
Cash and Cash Equivalents
As of September 30, 2017 and March 31, 2017, our cash and cash equivalents were $2,067 million and $2,565 million, respectively. Cash equivalents were valued using quoted market prices or other readily available market information.
Short-Term Investments
Short-term investments consisted of the following as of September 30, 2017 and March 31, 2017 (in millions): 
 
As of September 30, 2017
 
As of March 31, 2017
 
Cost or
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Cost or
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Gains
 
Losses
 
Gains
 
Losses
 
Corporate bonds
$
1,235

 
$

 
$
(1
)
 
$
1,234

 
$
944

 
$

 
$
(1
)
 
$
943

U.S. Treasury securities
410

 

 
(1
)
 
409

 
414

 

 
(1
)
 
413

U.S. agency securities
132

 

 
(1
)
 
131

 
152

 

 
(1
)
 
151

Commercial paper
268

 

 

 
268

 
212

 

 

 
212

Foreign government securities

101

 

 

 
101

 
113

 

 

 
113

Asset-backed securities
119

 

 

 
119

 
135

 

 

 
135

Certificates of deposit
26

 

 

 
26

 

 

 

 

Short-term investments
$
2,291

 
$

 
$
(3
)
 
$
2,288

 
$
1,970

 
$

 
$
(3
)
 
$
1,967


The following table summarizes the amortized cost and fair value of our short-term investments, classified by stated maturity as of September 30, 2017 and March 31, 2017 (in millions): 
 
As of September 30, 2017
 
As of March 31, 2017
 
Amortized
Cost
 
Fair
Value
 
Amortized
Cost
 
Fair
Value
Short-term investments
 
 
 
 
 
 
 
Due within 1 year
$
1,592

 
$
1,591

 
$
1,237

 
$
1,236

Due 1 year through 5 years
696

 
694

 
721

 
719

Due after 5 years
3

 
3

 
12

 
12

Short-term investments
$
2,291

 
$
2,288

 
$
1,970

 
$
1,967